Device Trial Radar · NCT06318130
Comparison of Pacing Lead Design on Left Bundle Branch Pacing Outcomes: The LEAD_LBBP Randomized Clinical Trial
Last checked: Nov 20, 2026Latest source record: Jun 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
210
Planned (sponsor's estimate)
Start
Jan 1, 2023
Primary completion
Oct 19, 2025
Study completion Oct 19, 2025
Sponsor
- Lead sponsor
- National University Hospital, SingaporeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 19, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This trial seeks to evaluate the performance of the extendable helix, stylet-driven pacing lead (SDL) compared to the fixed helix, lumenless pacing lead (LLL) during left bundle branch pacing (LBBP), with respect to enduring left bundle branch capture on follow-up, incidence of acute lead failure, pacing characteristics including QRS duration, pacing thresholds, R-wave amplitudes and lead impedance, and finally, safety profile during LBBP implantation. These data will guide future lead selection during LBBP implantation in achieving improved procedural success and optimal lead performance.
Conditions
- Pacemaker DDD
Interventions
Fixed helix, lumenless pacing lead.Device
Patients will be randomised to the fixed helix, lumenless pacing lead design during LBBP implantation.
Extendable helix, stylet-driven pacing lead.Device
Patients will be randomised to the extendable helix, stylet-driven pacing lead design during LBBP implantation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of loss of left bundle branch captureTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National University Heart Centre Singapore
Singapore, Singapore
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.